Angiodynamics (ANGO) Inventory (2011 - 2026)

Angiodynamics' Inventory history runs 16 years deep, the most recent figure standing at $52.4 million for Q2 2026.

• Quarterly Inventory fell 15.43% year-over-year to $52.4 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $52.4 million (down 15.43% YoY) and the FY2026 annual result came in at $52.4 million, down 15.43% from the prior year.
• Inventory was $52.4 million for Q2 2026 at Angiodynamics, down from $58.6 million in the prior quarter.
• Across five years, Inventory topped out at $65.9 million in Q4 2024 and bottomed at $48.0 million in Q1 2022.
• A 5-year average of $59.8 million and a median of $61.3 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory soared 32.25% — and 2026, when it dropped 15.43%.
• Angiodynamics' Inventory stood at $63.2 million in 2022, then rose by 1.7% to $64.3 million in 2023, then increased by 2.59% to $65.9 million in 2024, then retreated by 0.53% to $65.6 million in 2025, then dropped by 20.03% to $52.4 million in 2026.
• Business Quant data shows ANGO's Inventory at $52.4 million in Q2 2026, $58.6 million in Q1 2026, and $65.6 million in Q4 2025.